Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length

Leukemia. 2022 Jan;36(1):221-224. doi: 10.1038/s41375-021-01320-3. Epub 2021 Jun 19.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / genetics*
  • Clonal Hematopoiesis*
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / genetics
  • Multiple Myeloma / pathology*
  • Multiple Myeloma / therapy
  • Prognosis
  • RNA-Seq
  • Survival Rate
  • Telomere Homeostasis*

Substances

  • Biomarkers, Tumor